| Q4 FY26 Earnings Conference Call
Summary : Nath Bio-Genes shows strong FY26 growth and positive FY27 outlook, driven by diversification and R&D, despite climate and inventory challenges.
Management Perspective positive : FY26 has been a year of purposeful growth, one where our strategies have passed a period tangible to this, and where the trust that farmers, partners, and investors place in us has been well rewarded.We are excited about the opportunities that lie before us.We enter FY27 with confidence and purpose.It is always better to under commit and over perform. So, we are being conservative because we are just getting settled there.
Concall Report Analysis & Insights
Business Overview
- India's fifth-largest seed market, growing at 12-14% CAGR.
- FY26 revenue grew 19% to INR 4,316 million; EBITDA at INR 525 million.
- Cotton-paddy portfolio is 58% of revenue; maize volumes surged 54%.
- Uzbekistan JV contributed INR 15 crores, marking global expansion.
- Inventory increased to INR 4,446 million, reflecting confidence in FY27 demand.
Future Growth Prospects
- Robust pipeline of new varieties across key crops.
- Continued R&D investment and distribution network expansion.
- Deepening farmer engagement and international growth agenda.
- Expect 15-20% top line growth for FY27 with stable margins.
- Central Asia market offers significant long-term opportunity.
Management Insights
- FY26 was a year of purposeful growth, strategies rewarded.
- Indian seed sector offers compelling long-term opportunities.
- Diversification strategy is growing, with maize as a standout.
- Infrastructure strengthened, positioning for sustained leadership.
- Prepared for El Nino impact through balanced product portfolio.
Signs of Skepticism
- PAT declined 8% YoY despite 19% revenue growth.
- Tax rate increased from 5% to 11% YoY.
- Gross margin normalized from 63% to 56%.
- Negative cash flow for the financial year.
- Inventory increased significantly since March 2024.
Risk Factors
- Climate change and erratic monsoons pose agricultural challenges.
- Plant Nutrition segment declined due to China export restrictions.
- Increased finance costs from strategic working capital investment.
- Potential for negative cash flow due to inventory build-up.
Good To Know
- India's seed market is USD 4-4.5 billion, growing 12-14% CAGR.
- Government supports agriculture with PM-KISAN and digital missions.
- Uzbekistan cotton market is USD 100 million, Central Asia USD 450 million.
- Company aims for 10-15% of revenue from international operations.
- Cotton has a shelf life of five to seven years.
Key Drivers
- Strong 15-20% top line growth.
- Robust new product pipeline.
- Expanding international footprint.
- Government agricultural support.
Key Analyst Discussions
Competitive Environment
- Market share gains in cotton.
- Product life cycle and next-gen cotton pipeline.
- Portfolio diversification strategy.
Market Trends & Consumer Behavior
- Impact of El Nino on agriculture and demand.
- Adjustments for erratic monsoons.
- Preparedness for El Nino on trade receivables.
Financial Highlights
- FY27 revenue and EBITDA guidance.
- PAT decline, tax rate increase, and cash flow.
- Sales and marketing spend percentage.
- Inventory build-up and sales liquidation.
Product Composition
- Uzbekistan crops and revenue targets.
- International operations revenue percentage.
- Growth of non-cotton, non-paddy crops.
Strategic Considerations
- Planned CapEx investments for FY27.
- Balancing diversification with core strengths.
- Translating marketing spend to revenue growth.